RIGL

NASDAQ HEALTHCARE

Rigel Pharmaceuticals Inc

$37.45

-$1.62 (-4.15%)

Live quote

52w: $20.28 – $52.24

Loading chart…

P/E Ratio1.97

P/B Ratio1.81

EV/EBITDA—

Debt/Equity—

ROE91.78%

ROIC—

Revenue Growth64.15%

Gross Margin—

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is headquartered in South San Francisco, California.

Own RIGL? Track it here.

Create a free account to add RIGL to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account